DK1063998T3 - Drug for prophylaxis and / or treatment of mammary carcinoma containing a steroidal aromatase inhibitor - Google Patents

Drug for prophylaxis and / or treatment of mammary carcinoma containing a steroidal aromatase inhibitor

Info

Publication number
DK1063998T3
DK1063998T3 DK99913218T DK99913218T DK1063998T3 DK 1063998 T3 DK1063998 T3 DK 1063998T3 DK 99913218 T DK99913218 T DK 99913218T DK 99913218 T DK99913218 T DK 99913218T DK 1063998 T3 DK1063998 T3 DK 1063998T3
Authority
DK
Denmark
Prior art keywords
prophylaxis
treatment
drug
aromatase inhibitor
mammary carcinoma
Prior art date
Application number
DK99913218T
Other languages
Danish (da)
Inventor
Alfred Schmidt
Heinrich Wieland
Original Assignee
S W Patentverwertungs Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8231611&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1063998(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by S W Patentverwertungs Gmbh filed Critical S W Patentverwertungs Gmbh
Application granted granted Critical
Publication of DK1063998T3 publication Critical patent/DK1063998T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

The use of estrogen formation inhibitor(s) (I) is claimed for the preparation of a topical medicament for the prophylaxis and/or treatment of breast cancer.
DK99913218T 1998-03-18 1999-03-03 Drug for prophylaxis and / or treatment of mammary carcinoma containing a steroidal aromatase inhibitor DK1063998T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98104949A EP0943333A1 (en) 1998-03-18 1998-03-18 Medicament for the prevention and/or treatment of breast cancer comprising an inhibitor of estrogen synthesis
PCT/EP1999/001374 WO1999047143A1 (en) 1998-03-18 1999-03-03 Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor

Publications (1)

Publication Number Publication Date
DK1063998T3 true DK1063998T3 (en) 2003-05-12

Family

ID=8231611

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99913218T DK1063998T3 (en) 1998-03-18 1999-03-03 Drug for prophylaxis and / or treatment of mammary carcinoma containing a steroidal aromatase inhibitor

Country Status (19)

Country Link
EP (2) EP0943333A1 (en)
JP (1) JP4920822B2 (en)
KR (1) KR100778803B1 (en)
CN (1) CN1168448C (en)
AT (1) ATE230995T1 (en)
AU (1) AU751040B2 (en)
BR (1) BR9908885A (en)
CA (1) CA2324077C (en)
CZ (1) CZ292643B6 (en)
DE (1) DE59904042D1 (en)
DK (1) DK1063998T3 (en)
ES (1) ES2190201T3 (en)
HU (1) HU226105B1 (en)
ID (1) ID26965A (en)
IL (1) IL138292A (en)
PL (1) PL343100A1 (en)
RU (1) RU2225206C2 (en)
SK (1) SK285349B6 (en)
WO (1) WO1999047143A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10042411A1 (en) * 2000-08-30 2002-03-28 Lohmann Therapie Syst Lts Transdermal therapeutic system for the delivery of exemestane
DE10054294A1 (en) * 2000-11-02 2002-05-16 Heinrich Wieland Topical treatment for mastalgia
JP4524296B2 (en) * 2007-03-30 2010-08-11 生化学工業株式会社 Hair growth promoter
DE102007032468A1 (en) 2007-07-10 2009-01-15 Brätter, Christian, Dr. Transdermal therapeutic systems containing the active substance anastrozole
US11850451B2 (en) 2011-01-31 2023-12-26 Lucolas-M.D. Ltd. Cosmetic compositions and methods for improving skin conditions
KR20140040690A (en) * 2011-01-31 2014-04-03 루콜라스-엠.디. 리미티드 Cosmetic use
TR201816243T4 (en) 2011-01-31 2018-11-21 Lucolas M D Ltd Combinations of aromatase inhibitors and antioxidants.
EP3666276A1 (en) * 2018-12-14 2020-06-17 dcic Biopharmaceutical Limited Medication against estrogen-receptor beta (erbeta) positive breast tumor

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235893A (en) * 1978-05-08 1980-11-25 Brodie Angela M Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
DE3322285A1 (en) * 1983-06-18 1984-12-20 Schering AG, 1000 Berlin und 4709 Bergkamen 1-ALKYL-ANDROSTA-1,4-DIEN-3,17-DIONE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
FR2558373B1 (en) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre ANTI-ESTROGEN MEDICINAL PRODUCT BASED ON 4-HYDROXYTAMOXIFENE FOR PERCUTANEOUS ADMINISTRATION
JPS6345294A (en) * 1986-04-07 1988-02-26 Shionogi & Co Ltd Aromatase-inhibiting steroid derivative
EP0310542B1 (en) * 1987-10-01 1994-06-08 Schering Aktiengesellschaft Antigestagenic and antioestrogenic compounds for the treatment of hormone-dependent tumours
FR2656310B1 (en) * 1989-12-22 1992-05-07 Roussel Uclaf NEW STEROUID PRODUCTS COMPRISING IN POSITION 10, A SUBSTITUTED THIOETHYL RADICAL, THEIR PREPARATION METHOD AND THE INTERMEDIATES THEREOF, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DE4039559A1 (en) * 1990-12-07 1992-06-11 Schering Ag FUNCTIONALIZED VINYLAZOLES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING THIS VINYLAZOLES AND THE USE THEREOF FOR THE PRODUCTION OF MEDICINAL PRODUCTS
GB9212833D0 (en) * 1992-06-17 1992-07-29 Glaxo Group Ltd Chemical compounds
JP2810236B2 (en) * 1993-03-16 1998-10-15 フアイザー・インコーポレイテツド Naphthalene derivative
JPH07215992A (en) * 1993-12-07 1995-08-15 Teikoku Hormone Mfg Co Ltd 6-or 7-substituted androsra-1,4-diene derivative
JPH10508828A (en) * 1994-09-14 1998-09-02 セントラル シェフィールド ユニバーシティ ホスピタルズ エヌエイチエス トラスト Controlling hair growth
US5780050A (en) * 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
ES2156361T5 (en) * 1996-03-29 2012-12-26 Keyvest Gmbh Cosmetic or cosmetic composition for smoothing and smoothness of the skin in the case of affected adipose tissue, especially in the case of "cellulite"
EP0930876B2 (en) * 1996-07-22 2010-07-07 Renovo Limited Use of compounds that promote oestrogenic activity for acclerating the healing of skin wounds

Also Published As

Publication number Publication date
KR100778803B1 (en) 2007-11-27
JP2002506823A (en) 2002-03-05
SK13422000A3 (en) 2001-05-10
IL138292A (en) 2005-08-31
ID26965A (en) 2001-02-22
CA2324077C (en) 2008-07-29
EP0943333A1 (en) 1999-09-22
WO1999047143A1 (en) 1999-09-23
KR20010034603A (en) 2001-04-25
DE59904042D1 (en) 2003-02-20
JP4920822B2 (en) 2012-04-18
ATE230995T1 (en) 2003-02-15
CZ292643B6 (en) 2003-11-12
RU2225206C2 (en) 2004-03-10
SK285349B6 (en) 2006-11-03
EP1063998B1 (en) 2003-01-15
CN1168448C (en) 2004-09-29
BR9908885A (en) 2000-11-21
ES2190201T3 (en) 2003-07-16
CN1301165A (en) 2001-06-27
HU226105B1 (en) 2008-04-28
AU3143499A (en) 1999-10-11
CA2324077A1 (en) 1999-09-23
PL343100A1 (en) 2001-07-30
EP1063998A1 (en) 2001-01-03
IL138292A0 (en) 2001-10-31
AU751040B2 (en) 2002-08-08
CZ20003256A3 (en) 2001-04-11
HUP0101005A2 (en) 2001-08-28

Similar Documents

Publication Publication Date Title
DK1556058T3 (en) Pharmaceutical compositions comprising oestetrol derivatives for use in cancer therapy
NO20063853L (en) Combination therapy for osteoporosis
DK1401438T3 (en) Use of cyclopamine in the treatment of basal cell carcinoma and other tumors
ATE195530T1 (en) 17-ETHER AND THIOETHER OF 4-AZA STEROIDS
DE69332758D1 (en) TAXOL FOR TREATING LYMPHOMAS AND BREAST CANCER AND REDUCING MULTI-DRUG RESISTANCE TO TAXOL
DK279790A (en) AROMATIC STEROID-5-ALFA REDUCTASE INHIBITORS
DK1063998T3 (en) Drug for prophylaxis and / or treatment of mammary carcinoma containing a steroidal aromatase inhibitor
NO20024735L (en) Use of fulvestrant for the treatment of resistant breast cancer
NO994631D0 (en) Procedures and compositions for the treatment of ovarian cancer
RU2000126276A (en) A MEDICINE FOR PREVENTION AND / OR TREATMENT OF BREAST CANCER CONTAINING A STEROID AROMATASE INHIBITOR
DE69935156D1 (en) hCG THERAPY FOR THE TREATMENT OF METASTATIC BREAST CANCER
BR0114856A (en) Combination comprising camptothecin and a stilbene derivative for cancer treatment
IT1289154B1 (en) ISOFLAVONE DERIVATIVES THEIR PREPARATION AND THEIR THERAPEUTIC USE
AU1799392A (en) Use of mullerian inhibiting substance for treatment of certain tumors
IS5231A (en) Tissue factor affecting blood vessels
ES2145926T3 (en) METALLOCENIC DERIVATIVES OF DIARYLETHYLENE, PREPARATION METHODS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES.
ATE36333T1 (en) HYDANTOIN CONTAINING THERAPEUTIC AGENT.
NO885193D0 (en) COMPOSITIONS AND PROCEDURE FOR PROVIDING PREVENTION AND CONTROL OF BREAST CANCER.
DE60234995D1 (en) TATA CANCER
IT1241456B (en) MEDICALLY ASSOCIATION FOR THE TREATMENT OF HYPERTENSION AND CONGESTIVE CARDIAC INSUFFICIENCY. (CASE 100-7516)
RO86650B1 (en) Pharmaceuticcal preparation for treating dermatosis
DK1385497T3 (en) Prevention or treatment of breast, prostate and / or throat cancer with N, N-dimethylglycine